Learn more at LeadIQ.com

Insights

Leadership Appointments Recent key leadership appointments at Eliem Therapeutics, including the hiring of Dr. Aoife Brennan and Dr. Stephen Thomas as President and CEOs, present a strategic opportunity for sales engagement to explore potential partnerships or collaborations under new leadership.

Acquisitions and Investments Eliem Therapeutics' acquisition of Tenet Healthcare Corporation for $120M and a $120 million investment from RA Capital Management offer opportunities for sales by leveraging these deals to showcase growth potential and attract new investors or partners.

Technological Infrastructure Eliem's tech stack boasting Google Analytics, Shopify, Google Cloud, and more indicates a technologically advanced approach. Leveraging this advanced infrastructure in sales pitches can demonstrate efficiency, innovation, and a competitive edge to potential clients.

Publicly Traded Status As a publicly traded company listed on NASDAQ, Eliem Therapeutics' financial transparency and market visibility can be leveraged in sales conversations to build credibility, instill trust, and attract investment or partnership opportunities from stakeholders looking for established entities.

Strategic Focus on Neuronal Disorders Eliem's focus on developing therapies for neuronal excitability disorders like chronic pain and depression addresses critical unmet medical needs. Sales teams can capitalize on this strategic focus to highlight the company's potential to address large patient populations and collaborate on groundbreaking solutions.

Similar companies to Eliem Therapeutics

Eliem Therapeutics Tech Stack

Eliem Therapeutics uses 8 technology products and services including Google Analytics, MySQL, Shopify, and more. Explore Eliem Therapeutics's tech stack below.

Google Analytics
Analytics
MySQL
Database
Shopify
E-commerce
Google Font API
Font Scripts
Google Cloud
Infrastructure As A Service
Open Graph
Miscellaneous
Priority Hints
Performance
Nginx
Web Servers

Media & News

Eliem Therapeutics's Email Address Formats

Eliem Therapeutics uses at least 1 format(s):

Eliem Therapeutics Email Formats	Example	Percentage
First.Last@eliemtx.com	John.Doe@eliemtx.com	50%
First.Last@eliemtx.com	John.Doe@eliemtx.com	50%

Frequently Asked Questions

Where is Eliem Therapeutics's headquarters located?

Eliem Therapeutics's main headquarters is located at 15 Lake Bellevue Dr Suite 101 Bellevue, Washington 98005 US. The company has employees across 2 continents, including EuropeNorth America.

What is Eliem Therapeutics's stock symbol?

Eliem Therapeutics is a publicly traded company; the company's stock symbol is CLYM.

What is Eliem Therapeutics's official website and social media links?

Eliem Therapeutics's official website is eliemtx.com and has social profiles on LinkedIn.

How much revenue does Eliem Therapeutics generate?

As of August 2024, Eliem Therapeutics's annual revenue reached $1.8M.

What is Eliem Therapeutics's SIC code NAICS code?

Eliem Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Eliem Therapeutics have currently?

As of August 2024, Eliem Therapeutics has approximately 16 employees across 2 continents, including EuropeNorth America. Key team members include Chief Operating Officer And Chief Financial Officer: E. L.Interim Chief Business Officer: W. B.Vice President, Clinical Operations: J. M.. Explore Eliem Therapeutics's employee directory with LeadIQ.

What industry does Eliem Therapeutics belong to?

Eliem Therapeutics operates in the Biotechnology Research industry.

What technology does Eliem Therapeutics use?

Eliem Therapeutics's tech stack includes Google AnalyticsMySQLShopifyGoogle Font APIGoogle CloudOpen GraphPriority HintsNginx.

What is Eliem Therapeutics's email format?

Eliem Therapeutics's email format typically follows the pattern of . Find more Eliem Therapeutics email formats with LeadIQ.

How much funding has Eliem Therapeutics raised to date?

As of August 2024, Eliem Therapeutics has raised $120M in funding. The last funding round occurred on Jun 27, 2024 for $120M.

When was Eliem Therapeutics founded?

Eliem Therapeutics was founded in 2018.

Eliem Therapeutics

Eliem Therapeutics

Biotechnology ResearchWashington, United States11-50 Employees

Eliem Therapeutics is a biotechnology company delivering therapies that empower patients to live on their own terms.  Locations in US, with R&D operations in Cambridge, UK, Eliem channels its experience, energy, and passion for improving patients’ quality of life by developing and commercializing potentially “best-in-class” drug candidates to treat neuronal excitability disorders. These conditions—such as chronic pain, depression, epilepsy, and anxiety—cause deep suffering for tens of millions of people each day. At its core, the Eliem team is motivated by the promise of helping patients live happier, more fulfilling lives.   Eliem is a publicly traded company (NASDAQ: ELYM)

Read our community guidelines here: https://eliemtx.com/community-engagement-guidelines/

Company Overview

Headquarters: 15 Lake Bellevue Dr Suite 101 Bellevue, Washington 98005 US
Website: eliemtx.com
SIC Code: 8733 - Noncommercial Research Organizations
Stock Symbol: CLYM
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2018
Employees: 11-50

Media & News

Funding & Financials

$120M
Eliem Therapeutics has raised a total of $120M of funding over 7 rounds. Their latest funding round was raised on Jun 27, 2024 in the amount of $120M.
$10M
Eliem Therapeutics's revenue is in the range of $10M

Funding & Financials

$120M
Eliem Therapeutics has raised a total of $120M of funding over 7 rounds. Their latest funding round was raised on Jun 27, 2024 in the amount of $120M.
$10M
Eliem Therapeutics's revenue is in the range of $10M

Company Leadership

E. L.
Chief Operating Officer And Chief Financial Officer
✕
Access Insights for Eliem Therapeutics and Millions of Other Companies
Sign up for full access to Eliem Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Eliem Therapeutics and Millions of Other Companies
Sign up for full access to Eliem Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
W. B.
Interim Chief Business Officer
✕
Access Insights for Eliem Therapeutics and Millions of Other Companies
Sign up for full access to Eliem Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Eliem Therapeutics and Millions of Other Companies
Sign up for full access to Eliem Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. M.
Vice President, Clinical Operations
✕
Access Insights for Eliem Therapeutics and Millions of Other Companies
Sign up for full access to Eliem Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Eliem Therapeutics and Millions of Other Companies
Sign up for full access to Eliem Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
S. F.
Sr. Vice President, Head Of Regulatory Affairs
✕
Access Insights for Eliem Therapeutics and Millions of Other Companies
Sign up for full access to Eliem Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Eliem Therapeutics and Millions of Other Companies
Sign up for full access to Eliem Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
R. V.
Director Of Clinical Operations
✕
Access Insights for Eliem Therapeutics and Millions of Other Companies
Sign up for full access to Eliem Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Eliem Therapeutics and Millions of Other Companies
Sign up for full access to Eliem Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

N. N.
Controller/Director Of Accounting
✕
Access Insights for Eliem Therapeutics and Millions of Other Companies
Sign up for full access to Eliem Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Eliem Therapeutics and Millions of Other Companies
Sign up for full access to Eliem Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
H. R.
Senior Finance Manager
✕
Access Insights for Eliem Therapeutics and Millions of Other Companies
Sign up for full access to Eliem Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Eliem Therapeutics and Millions of Other Companies
Sign up for full access to Eliem Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.